Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41


Barriers Rural Physicians Face Prescribing Buprenorphine for Opioid Use Disorder.

Andrilla CHA, Coulthard C, Larson EH.

Ann Fam Med. 2017 Jul;15(4):359-362. doi: 10.1370/afm.2099.


Public sector low threshold office-based buprenorphine treatment: outcomes at year 7.

Bhatraju EP, Grossman E, Tofighi B, McNeely J, DiRocco D, Flannery M, Garment A, Goldfeld K, Gourevitch MN, Lee JD.

Addict Sci Clin Pract. 2017 Feb 28;12(1):7. doi: 10.1186/s13722-017-0072-2.


Strategies and policies to address the opioid epidemic: A case study of Ohio.

Penm J, MacKinnon NJ, Boone JM, Ciaccia A, McNamee C, Winstanley EL.

J Am Pharm Assoc (2003). 2017 Mar - Apr;57(2S):S148-S153. doi: 10.1016/j.japh.2017.01.001. Epub 2017 Feb 8.


The Role of Behavioral Interventions in Buprenorphine Maintenance Treatment: A Review.

Carroll KM, Weiss RD.

Am J Psychiatry. 2016 Dec 16:appiajp201616070792. [Epub ahead of print]


The Availability of Ancillary Counseling in the Practices of Physicians Prescribing Buprenorphine.

Barry DT, Fazzino T, Necrason E, Ginn J, Fiellin LE, Fiellin DA, Moore BA.

J Addict Med. 2016 Sep-Oct;10(5):352-6. doi: 10.1097/ADM.0000000000000247.


Access to Addiction Pharmacotherapy in Private Health Plans.

Reif S, Horgan CM, Hodgkin D, Matteucci AM, Creedon TB, Stewart MT.

J Subst Abuse Treat. 2016 Jul;66:23-9. doi: 10.1016/j.jsat.2016.03.001. Epub 2016 Mar 14.


Buprenorphine Maintenance for Opioid Dependence in Public Sector Healthcare: Benefits and Barriers.

Duncan LG, Mendoza S, Hansen H.

J Addict Med Ther Sci. 2015;1(2):31-36. Epub 2015 Aug 3.


Using a Learning Collaborative Strategy With Office-based Practices to Increase Access and Improve Quality of Care for Patients With Opioid Use Disorders.

Nordstrom BR, Saunders EC, McLeman B, Meier A, Xie H, Lambert-Harris C, Tanzman B, Brooklyn J, King G, Kloster N, Lord CF, Roberts W, McGovern MP.

J Addict Med. 2016 Mar-Apr;10(2):117-23. doi: 10.1097/ADM.0000000000000200.


Cost-effectiveness of an internet-delivered treatment for substance abuse: Data from a multisite randomized controlled trial.

Murphy SM, Campbell AN, Ghitza UE, Kyle TL, Bailey GL, Nunes EV, Polsky D.

Drug Alcohol Depend. 2016 Apr 1;161:119-26. doi: 10.1016/j.drugalcdep.2016.01.021. Epub 2016 Jan 30.


Buprenorphine Prescribing Availability in a Sample of Ohio Specialty Treatment Organizations.

Molfenter T, Sherbeck C, Zehner M, Starr S.

J Addict Behav Ther Rehabil. 2015;4(2). pii: 1000140.


Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties.

Stein BD, Pacula RL, Gordon AJ, Burns RM, Leslie DL, Sorbero MJ, Bauhoff S, Mandell TW, Dick AW.

Milbank Q. 2015 Sep;93(3):561-83. doi: 10.1111/1468-0009.12137.


Office-Based Opioid Treatment with Buprenorphine (OBOT-B): Statewide Implementation of the Massachusetts Collaborative Care Model in Community Health Centers.

LaBelle CT, Han SC, Bergeron A, Samet JH.

J Subst Abuse Treat. 2016 Jan;60:6-13. doi: 10.1016/j.jsat.2015.06.010. Epub 2015 Jun 26.


National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment.

Jones CM, Campopiano M, Baldwin G, McCance-Katz E.

Am J Public Health. 2015 Aug;105(8):e55-63. doi: 10.2105/AJPH.2015.302664. Epub 2015 Jun 11.


Growth In Buprenorphine Waivers For Physicians Increased Potential Access To Opioid Agonist Treatment, 2002-11.

Dick AW, Pacula RL, Gordon AJ, Sorbero M, Burns RM, Leslie D, Stein BD.

Health Aff (Millwood). 2015 Jun;34(6):1028-34. doi: 10.1377/hlthaff.2014.1205.


Implementing buprenorphine in addiction treatment: payer and provider perspectives in Ohio.

Molfenter T, Sherbeck C, Zehner M, Quanbeck A, McCarty D, Kim JS, Starr S.

Subst Abuse Treat Prev Policy. 2015 Mar 28;10:13. doi: 10.1186/s13011-015-0009-2.


Geographic and specialty distribution of US physicians trained to treat opioid use disorder.

Rosenblatt RA, Andrilla CH, Catlin M, Larson EH.

Ann Fam Med. 2015 Jan-Feb;13(1):23-6. doi: 10.1370/afm.1735.


The prescription of addiction medications after implementation of chronic care management for substance dependence in primary care.

Park TW, Samet JH, Cheng DM, Winter MR, Kim TW, Fitzgerald A, Saitz R.

J Subst Abuse Treat. 2015 May;52:17-23. doi: 10.1016/j.jsat.2014.11.008. Epub 2014 Dec 2.


Preliminary survey of office-based opioid treatment practices and attitudes among psychiatrists never receiving buprenorphine training to those who received training during residency.

Suzuki J, Connery HS, Ellison TV, Renner JA.

Am J Addict. 2014 Nov-Dec;23(6):618-22. doi: 10.1111/j.1521-0391.2014.12143.x. Epub 2014 Jul 25.

Supplemental Content

Support Center